Atrium Health Ltd is a leading pharmaceutical company in Bangladesh established in the year 2008. The company has a very big manufacturing facility located at Pabna. Since its beginning, Atrium Health Ltd has been launching new and innovative products in order to fulfill unmet demand of the medical community. The focus has been to bring more new technologically advanced molecules to this country.
Atrium Health Ltd has a very competent sales team, which promotes the specialties throughout the country. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 18 depots all over the country. The company has a clear vision to become a leading research based dosage form manufacturing company with global presence within a short period of time. With this view in mind the company started to expand its business in overseas markets. Currently Atrium Health Ltd exports to different countries around the world. With hundreds of brands registered in different countries, and many more in the pipeline, Atrium Health Ltd is gradually expanding its global footprint across all the continents.
The company is continuously expanding its activities beyond the geographical boundary of Bangladesh. The company is open to collaborate with interested and relevant parties in various countries. Atrium Health Ltd will continue to strive to provide high quality medicine at affordable prices to the people here in Bangladesh and other parts of the globe.
First of all, we strive for top quality health care goods at the least cost reaching the lowest category of the economic class of people in the country.
We value our social obligations. We also strive, as responsible citizens, for a social order devoid of malpractices, anti-environmental behaviors, unethical and corruptive dealings.
Atrium Health Ltd manufactures and sells a wide range of products in the local and international market. We are committed to introduce more technologically advanced quality products at an affordable price in the future.